Ann Marie MullallyMD
Dr. Ann Mullally is a physician-scientist at Brigham and Women’s Hospital (BWH) / Dana-Farber Cancer Institute (DFCI). Her laboratory studies the genetics, biology, and therapy of myeloproliferative neoplasms (MPN) using MPN patient samples, mouse models and multiple different laboratories approaches. Dr. Mullally’s MPN research interests include myelofibrosis, the biology of mutant calreticulin (CALR) in MPN, JAK2V617F MPN stem cells, improving the efficacy of JAK2 inhibitors and familial forms of MPN. The overarching goal of the research in her laboratory is to advance the understanding of the biology of MPN and to translate this into improved treatment options for patients dealing with these diseases.